nodes	percent_of_prediction	percent_of_DWPC	metapath
Plerixafor—CXCR4—respiratory system—asthma	0.0176	0.144	CbGeAlD
Plerixafor—CXCR4—adrenal cortex—asthma	0.0148	0.121	CbGeAlD
Plerixafor—CXCR4—epithelium—asthma	0.0147	0.12	CbGeAlD
Plerixafor—CXCR4—bronchus—asthma	0.0145	0.118	CbGeAlD
Plerixafor—CXCR4—smooth muscle tissue—asthma	0.0142	0.116	CbGeAlD
Plerixafor—CXCR4—cardiovascular system—asthma	0.0135	0.11	CbGeAlD
Plerixafor—CXCR4—trachea—asthma	0.013	0.106	CbGeAlD
Plerixafor—CXCR4—adrenal gland—asthma	0.0107	0.0872	CbGeAlD
Plerixafor—CXCR4—lung—asthma	0.00934	0.0765	CbGeAlD
Plerixafor—CXCR4—GPCR ligand binding—TACR1—asthma	0.000764	0.00191	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—LTB4R—asthma	0.000752	0.00188	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—PTGDR—asthma	0.000752	0.00188	CbGpPWpGaD
Plerixafor—CXCR4—Peptide ligand-binding receptors—CCR5—asthma	0.000749	0.00188	CbGpPWpGaD
Plerixafor—CXCR4—GPCRs, Class A Rhodopsin-like—ADRB2—asthma	0.000735	0.00184	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—C3AR1—asthma	0.000734	0.00184	CbGpPWpGaD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—BDKRB2—asthma	0.000733	0.00184	CbGpPWpGaD
Plerixafor—CXCR4—Peptide ligand-binding receptors—C3—asthma	0.000732	0.00183	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—CYSLTR2—asthma	0.000707	0.00177	CbGpPWpGaD
Plerixafor—CXCR4—G alpha (i) signalling events—CCL5—asthma	0.000702	0.00176	CbGpPWpGaD
Plerixafor—CXCR4—CXCR4-mediated signaling events—STAT3—asthma	0.0007	0.00175	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—CCR3—asthma	0.000699	0.00175	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—LTB4R—asthma	0.000683	0.00171	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—PTGDR—asthma	0.000683	0.00171	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—CCL22—asthma	0.000683	0.00171	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—NPY—asthma	0.000681	0.0017	CbGpPWpGaD
Plerixafor—CXCR4—HIV Infection—CCR5—asthma	0.000676	0.00169	CbGpPWpGaD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—KNG1—asthma	0.000667	0.00167	CbGpPWpGaD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—AGTR1—asthma	0.000663	0.00166	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—AGTR2—asthma	0.000657	0.00164	CbGpPWpGaD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—CXCL10—asthma	0.000648	0.00162	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—HRH4—asthma	0.000639	0.0016	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—PMCH—asthma	0.000639	0.0016	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—NPSR1—asthma	0.000639	0.0016	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—PTGDR2—asthma	0.000639	0.0016	CbGpPWpGaD
Plerixafor—CXCR4—G alpha (i) signalling events—CCR5—asthma	0.000632	0.00158	CbGpPWpGaD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—ADRB2—asthma	0.000629	0.00157	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—EDNRB—asthma	0.000629	0.00157	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—CSF2RB—asthma	0.000625	0.00156	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—NPS—asthma	0.000623	0.00156	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—TAC1—asthma	0.000623	0.00156	CbGpPWpGaD
Plerixafor—CXCR4—G alpha (i) signalling events—C3—asthma	0.000618	0.00155	CbGpPWpGaD
Plerixafor—CXCR4—HIV Life Cycle—CD4—asthma	0.000615	0.00154	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—TACR2—asthma	0.000613	0.00153	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—CCR8—asthma	0.000613	0.00153	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—CXCR3—asthma	0.000611	0.00153	CbGpPWpGaD
Plerixafor—CXCR4—GPCRs, Class A Rhodopsin-like—CCR5—asthma	0.000587	0.00147	CbGpPWpGaD
Plerixafor—CXCR4—Peptide ligand-binding receptors—POMC—asthma	0.000586	0.00147	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—NPSR1—asthma	0.00058	0.00145	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—PTGDR2—asthma	0.00058	0.00145	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—HRH4—asthma	0.00058	0.00145	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—PMCH—asthma	0.00058	0.00145	CbGpPWpGaD
Plerixafor—CXCR4—Peptide ligand-binding receptors—CCL2—asthma	0.000573	0.00143	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—CSF2RB—asthma	0.000568	0.00142	CbGpPWpGaD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—EDN1—asthma	0.000562	0.00141	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—BDKRB2—asthma	0.000559	0.0014	CbGpPWpGaD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—CCL5—asthma	0.000558	0.0014	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—CCR8—asthma	0.000556	0.00139	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—TACR2—asthma	0.000556	0.00139	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—CCL17—asthma	0.000546	0.00137	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—PDE4A—asthma	0.000536	0.00134	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—KNG1—asthma	0.000508	0.00127	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—AGTR1—asthma	0.000505	0.00126	CbGpPWpGaD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—CCR5—asthma	0.000503	0.00126	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—CYSLTR1—asthma	0.000502	0.00125	CbGpPWpGaD
Plerixafor—CXCR4—G alpha (i) signalling events—POMC—asthma	0.000494	0.00124	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—CXCL10—asthma	0.000494	0.00123	CbGpPWpGaD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—C3—asthma	0.000491	0.00123	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—PDE4A—asthma	0.000486	0.00122	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—VIP—asthma	0.000484	0.00121	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—C5AR1—asthma	0.000484	0.00121	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—UTS2—asthma	0.000484	0.00121	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—ADRB2—asthma	0.000479	0.0012	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—CCR4—asthma	0.000464	0.00116	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—CYSLTR1—asthma	0.000455	0.00114	CbGpPWpGaD
Plerixafor—CXCR4—Peptide ligand-binding receptors—CXCL8—asthma	0.000453	0.00113	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—IL2RB—asthma	0.000447	0.00112	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—PDE4D—asthma	0.000443	0.00111	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—VIP—asthma	0.00044	0.0011	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—UTS2—asthma	0.00044	0.0011	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—C5AR1—asthma	0.00044	0.0011	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—CCL11—asthma	0.00044	0.0011	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—FCER2—asthma	0.000434	0.00109	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—C3AR1—asthma	0.000434	0.00109	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—C5—asthma	0.000432	0.00108	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—PDE4B—asthma	0.000432	0.00108	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—TACR1—asthma	0.000432	0.00108	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—EDN1—asthma	0.000428	0.00107	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—CCL5—asthma	0.000425	0.00106	CbGpPWpGaD
Plerixafor—CXCR4—HIV Infection—CD4—asthma	0.000425	0.00106	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—CCR4—asthma	0.000422	0.00105	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CYSLTR2—asthma	0.000417	0.00104	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—IL2RB—asthma	0.000406	0.00102	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CCL22—asthma	0.000403	0.00101	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—LTB4R—asthma	0.000403	0.00101	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—PTGDR—asthma	0.000403	0.00101	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—PDE4D—asthma	0.000402	0.00101	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—CCR3—asthma	0.000395	0.000988	CbGpPWpGaD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—POMC—asthma	0.000393	0.000983	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—PDE4B—asthma	0.000392	0.000981	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—C5—asthma	0.000392	0.000981	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—TACR1—asthma	0.000392	0.000981	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—NPY—asthma	0.000385	0.000963	CbGpPWpGaD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—CCL2—asthma	0.000384	0.000962	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—CCR5—asthma	0.000383	0.000958	CbGpPWpGaD
Plerixafor—CXCR4—G alpha (i) signalling events—CXCL8—asthma	0.000382	0.000956	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—C3—asthma	0.000374	0.000936	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—AGTR2—asthma	0.000371	0.000929	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—CCR3—asthma	0.000359	0.000897	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—EDNRB—asthma	0.000356	0.000889	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—TAC1—asthma	0.000352	0.00088	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—NPS—asthma	0.000352	0.00088	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—NPY—asthma	0.000349	0.000874	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—CXCR3—asthma	0.000345	0.000863	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—NPSR1—asthma	0.000343	0.000858	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—HRH4—asthma	0.000343	0.000858	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—PTGDR2—asthma	0.000343	0.000858	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—PMCH—asthma	0.000343	0.000858	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—AGTR2—asthma	0.000337	0.000843	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CSF2RB—asthma	0.000336	0.000839	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—TACR2—asthma	0.000329	0.000822	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CCR8—asthma	0.000329	0.000822	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—IL5—asthma	0.000327	0.000819	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—EDNRB—asthma	0.000323	0.000808	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CCL17—asthma	0.000322	0.000806	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—TAC1—asthma	0.00032	0.0008	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—NPS—asthma	0.00032	0.0008	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—BDKRB2—asthma	0.000316	0.00079	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—CXCR3—asthma	0.000313	0.000784	CbGpPWpGaD
Plerixafor—CXCR4—Disease—DCN—asthma	0.000311	0.000778	CbGpPWpGaD
Plerixafor—Asthenia—Budesonide—asthma	0.000309	0.000646	CcSEcCtD
Plerixafor—Mental disorder—Hydrocortisone—asthma	0.000307	0.000642	CcSEcCtD
Plerixafor—CXCR4—GPCR downstream signaling—ADCY2—asthma	0.000305	0.000764	CbGpPWpGaD
Plerixafor—Erythema—Hydrocortisone—asthma	0.000305	0.000638	CcSEcCtD
Plerixafor—Dizziness—Montelukast—asthma	0.000305	0.000638	CcSEcCtD
Plerixafor—Pruritus—Budesonide—asthma	0.000305	0.000637	CcSEcCtD
Plerixafor—CXCR4—GPCR downstream signaling—IL3—asthma	0.000304	0.000761	CbGpPWpGaD
Plerixafor—Diarrhoea—Salbutamol—asthma	0.000304	0.000636	CcSEcCtD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—CXCL8—asthma	0.000304	0.00076	CbGpPWpGaD
Plerixafor—Haemoglobin—Betamethasone—asthma	0.000301	0.00063	CcSEcCtD
Plerixafor—Haemoglobin—Dexamethasone—asthma	0.000301	0.00063	CcSEcCtD
Plerixafor—Haemorrhage—Betamethasone—asthma	0.0003	0.000626	CcSEcCtD
Plerixafor—Haemorrhage—Dexamethasone—asthma	0.0003	0.000626	CcSEcCtD
Plerixafor—Vomiting—Arformoterol—asthma	0.000299	0.000626	CcSEcCtD
Plerixafor—Vomiting—Formoterol—asthma	0.000299	0.000626	CcSEcCtD
Plerixafor—CXCR4—GPCR ligand binding—POMC—asthma	0.000299	0.000749	CbGpPWpGaD
Plerixafor—Nausea—Mometasone—asthma	0.000298	0.000623	CcSEcCtD
Plerixafor—Immune system disorder—Methylprednisolone—asthma	0.000298	0.000622	CcSEcCtD
Plerixafor—CXCR4—Signaling by GPCR—IL5—asthma	0.000297	0.000743	CbGpPWpGaD
Plerixafor—Rash—Formoterol—asthma	0.000297	0.000621	CcSEcCtD
Plerixafor—Rash—Arformoterol—asthma	0.000297	0.000621	CcSEcCtD
Plerixafor—Dermatitis—Arformoterol—asthma	0.000297	0.00062	CcSEcCtD
Plerixafor—Dermatitis—Formoterol—asthma	0.000297	0.00062	CcSEcCtD
Plerixafor—Headache—Arformoterol—asthma	0.000295	0.000617	CcSEcCtD
Plerixafor—Headache—Formoterol—asthma	0.000295	0.000617	CcSEcCtD
Plerixafor—Diarrhoea—Budesonide—asthma	0.000295	0.000616	CcSEcCtD
Plerixafor—Dizziness—Salbutamol—asthma	0.000294	0.000615	CcSEcCtD
Plerixafor—Vomiting—Montelukast—asthma	0.000293	0.000613	CcSEcCtD
Plerixafor—CXCR4—GPCR ligand binding—CCL2—asthma	0.000293	0.000732	CbGpPWpGaD
Plerixafor—Rash—Montelukast—asthma	0.000291	0.000608	CcSEcCtD
Plerixafor—Dermatitis—Montelukast—asthma	0.000291	0.000608	CcSEcCtD
Plerixafor—Ill-defined disorder—Prednisolone—asthma	0.00029	0.000606	CcSEcCtD
Plerixafor—Headache—Montelukast—asthma	0.000289	0.000604	CcSEcCtD
Plerixafor—Mental disorder—Methylprednisolone—asthma	0.000289	0.000604	CcSEcCtD
Plerixafor—Erythema—Triamcinolone—asthma	0.000287	0.000601	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—KIF3A—asthma	0.000287	0.000719	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—PDE4A—asthma	0.000287	0.000719	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—KNG1—asthma	0.000287	0.000718	CbGpPWpGaD
Plerixafor—Erythema—Methylprednisolone—asthma	0.000287	0.0006	CcSEcCtD
Plerixafor—CXCR4—Signaling by GPCR—BDKRB2—asthma	0.000287	0.000717	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—AGTR1—asthma	0.000285	0.000714	CbGpPWpGaD
Plerixafor—Dizziness—Budesonide—asthma	0.000285	0.000596	CcSEcCtD
Plerixafor—Ill-defined disorder—Hydrocortisone—asthma	0.000283	0.000592	CcSEcCtD
Plerixafor—Vomiting—Salbutamol—asthma	0.000283	0.000591	CcSEcCtD
Plerixafor—Malaise—Prednisolone—asthma	0.000282	0.000589	CcSEcCtD
Plerixafor—Rash—Salbutamol—asthma	0.00028	0.000586	CcSEcCtD
Plerixafor—Syncope—Prednisolone—asthma	0.00028	0.000586	CcSEcCtD
Plerixafor—Dermatitis—Salbutamol—asthma	0.00028	0.000586	CcSEcCtD
Plerixafor—Nausea—Formoterol—asthma	0.00028	0.000585	CcSEcCtD
Plerixafor—Nausea—Arformoterol—asthma	0.00028	0.000585	CcSEcCtD
Plerixafor—CXCR4—GPCR downstream signaling—CXCL10—asthma	0.000279	0.000698	CbGpPWpGaD
Plerixafor—Headache—Salbutamol—asthma	0.000279	0.000583	CcSEcCtD
Plerixafor—CXCR4—Signaling by GPCR—ADCY2—asthma	0.000277	0.000694	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—IL3—asthma	0.000276	0.000691	CbGpPWpGaD
Plerixafor—Malaise—Hydrocortisone—asthma	0.000275	0.000576	CcSEcCtD
Plerixafor—Loss of consciousness—Prednisolone—asthma	0.000275	0.000574	CcSEcCtD
Plerixafor—Nausea—Montelukast—asthma	0.000274	0.000573	CcSEcCtD
Plerixafor—Vomiting—Budesonide—asthma	0.000274	0.000573	CcSEcCtD
Plerixafor—Syncope—Hydrocortisone—asthma	0.000274	0.000572	CcSEcCtD
Plerixafor—Rash—Budesonide—asthma	0.000272	0.000568	CcSEcCtD
Plerixafor—Dermatitis—Budesonide—asthma	0.000271	0.000567	CcSEcCtD
Plerixafor—CXCR4—GPCR downstream signaling—ADRB2—asthma	0.000271	0.000678	CbGpPWpGaD
Plerixafor—Headache—Budesonide—asthma	0.00027	0.000564	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—CYSLTR1—asthma	0.000269	0.000673	CbGpPWpGaD
Plerixafor—Loss of consciousness—Hydrocortisone—asthma	0.000268	0.000561	CcSEcCtD
Plerixafor—Ill-defined disorder—Triamcinolone—asthma	0.000267	0.000558	CcSEcCtD
Plerixafor—Ill-defined disorder—Methylprednisolone—asthma	0.000266	0.000556	CcSEcCtD
Plerixafor—Nausea—Salbutamol—asthma	0.000264	0.000552	CcSEcCtD
Plerixafor—Discomfort—Prednisolone—asthma	0.000263	0.00055	CcSEcCtD
Plerixafor—Haemoglobin—Prednisone—asthma	0.000262	0.000548	CcSEcCtD
Plerixafor—Haemorrhage—Prednisone—asthma	0.000261	0.000546	CcSEcCtD
Plerixafor—CXCR4—Signaling by GPCR—KNG1—asthma	0.000261	0.000652	CbGpPWpGaD
Plerixafor—Erythema—Betamethasone—asthma	0.000261	0.000545	CcSEcCtD
Plerixafor—Erythema—Dexamethasone—asthma	0.000261	0.000545	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—VIP—asthma	0.00026	0.00065	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CMA1—asthma	0.00026	0.00065	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—UTS2—asthma	0.00026	0.00065	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CCL11—asthma	0.00026	0.00065	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—C5AR1—asthma	0.00026	0.00065	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—AGTR1—asthma	0.000259	0.000649	CbGpPWpGaD
Plerixafor—Malaise—Triamcinolone—asthma	0.000259	0.000542	CcSEcCtD
Plerixafor—Malaise—Methylprednisolone—asthma	0.000259	0.000541	CcSEcCtD
Plerixafor—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—asthma	0.000258	0.00054	CcSEcCtD
Plerixafor—Syncope—Triamcinolone—asthma	0.000258	0.000539	CcSEcCtD
Plerixafor—Syncope—Methylprednisolone—asthma	0.000257	0.000538	CcSEcCtD
Plerixafor—Discomfort—Hydrocortisone—asthma	0.000257	0.000537	CcSEcCtD
Plerixafor—Connective tissue disorder—Prednisone—asthma	0.000256	0.000536	CcSEcCtD
Plerixafor—CXCR4—GPCR downstream signaling—ITPR1—asthma	0.000256	0.000641	CbGpPWpGaD
Plerixafor—CXCR4—Disease—CYBA—asthma	0.000256	0.000641	CbGpPWpGaD
Plerixafor—Nausea—Budesonide—asthma	0.000256	0.000535	CcSEcCtD
Plerixafor—Anaphylactic shock—Prednisolone—asthma	0.000255	0.000533	CcSEcCtD
Plerixafor—CXCR4—Signaling by GPCR—CXCL10—asthma	0.000253	0.000634	CbGpPWpGaD
Plerixafor—Loss of consciousness—Triamcinolone—asthma	0.000253	0.000528	CcSEcCtD
Plerixafor—Loss of consciousness—Methylprednisolone—asthma	0.000252	0.000527	CcSEcCtD
Plerixafor—Shock—Prednisolone—asthma	0.000251	0.000525	CcSEcCtD
Plerixafor—CXCR4—Disease—PARP1—asthma	0.000251	0.000627	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CCR4—asthma	0.000249	0.000623	CbGpPWpGaD
Plerixafor—Anaphylactic shock—Hydrocortisone—asthma	0.000249	0.000521	CcSEcCtD
Plerixafor—Hyperhidrosis—Prednisolone—asthma	0.000247	0.000516	CcSEcCtD
Plerixafor—CXCR4—Signaling by GPCR—ADRB2—asthma	0.000246	0.000615	CbGpPWpGaD
Plerixafor—Shock—Hydrocortisone—asthma	0.000245	0.000513	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—STAT6—asthma	0.000244	0.000611	CbGpPWpGaD
Plerixafor—Nervous system disorder—Hydrocortisone—asthma	0.000244	0.000511	CcSEcCtD
Plerixafor—Arthralgia—Methylprednisolone—asthma	0.000244	0.000511	CcSEcCtD
Plerixafor—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—asthma	0.000242	0.000507	CcSEcCtD
Plerixafor—CXCR4—GPCR downstream signaling—EDN1—asthma	0.000242	0.000605	CbGpPWpGaD
Plerixafor—Skin disorder—Hydrocortisone—asthma	0.000242	0.000506	CcSEcCtD
Plerixafor—Ill-defined disorder—Dexamethasone—asthma	0.000242	0.000506	CcSEcCtD
Plerixafor—Ill-defined disorder—Betamethasone—asthma	0.000242	0.000506	CcSEcCtD
Plerixafor—Discomfort—Triamcinolone—asthma	0.000242	0.000506	CcSEcCtD
Plerixafor—Discomfort—Methylprednisolone—asthma	0.000241	0.000504	CcSEcCtD
Plerixafor—Hyperhidrosis—Hydrocortisone—asthma	0.000241	0.000504	CcSEcCtD
Plerixafor—CXCR4—GPCR downstream signaling—CCL5—asthma	0.00024	0.000601	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—IL2RB—asthma	0.00024	0.0006	CbGpPWpGaD
Plerixafor—Dry mouth—Triamcinolone—asthma	0.000239	0.0005	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—PDE4D—asthma	0.000238	0.000595	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—CSF2—asthma	0.000237	0.000592	CbGpPWpGaD
Plerixafor—CXCR4—Disease—NOS1—asthma	0.000236	0.00059	CbGpPWpGaD
Plerixafor—Immune system disorder—Prednisone—asthma	0.000236	0.000493	CcSEcCtD
Plerixafor—Malaise—Betamethasone—asthma	0.000235	0.000492	CcSEcCtD
Plerixafor—Malaise—Dexamethasone—asthma	0.000235	0.000492	CcSEcCtD
Plerixafor—Anaphylactic shock—Triamcinolone—asthma	0.000235	0.000491	CcSEcCtD
Plerixafor—Anaphylactic shock—Methylprednisolone—asthma	0.000234	0.000489	CcSEcCtD
Plerixafor—CXCR4—Disease—ADCY2—asthma	0.000234	0.000585	CbGpPWpGaD
Plerixafor—Syncope—Betamethasone—asthma	0.000234	0.000489	CcSEcCtD
Plerixafor—Syncope—Dexamethasone—asthma	0.000234	0.000489	CcSEcCtD
Plerixafor—CXCR4—Signaling by GPCR—ITPR1—asthma	0.000233	0.000582	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—PDE4B—asthma	0.000232	0.000579	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—C5—asthma	0.000232	0.000579	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—TACR1—asthma	0.000232	0.000579	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—CXCL8—asthma	0.000231	0.000579	CbGpPWpGaD
Plerixafor—Shock—Triamcinolone—asthma	0.000231	0.000483	CcSEcCtD
Plerixafor—Insomnia—Prednisolone—asthma	0.000231	0.000482	CcSEcCtD
Plerixafor—Shock—Methylprednisolone—asthma	0.00023	0.000482	CcSEcCtD
Plerixafor—Nervous system disorder—Methylprednisolone—asthma	0.000229	0.00048	CcSEcCtD
Plerixafor—Loss of consciousness—Dexamethasone—asthma	0.000229	0.000479	CcSEcCtD
Plerixafor—Loss of consciousness—Betamethasone—asthma	0.000229	0.000479	CcSEcCtD
Plerixafor—Paraesthesia—Prednisolone—asthma	0.000229	0.000479	CcSEcCtD
Plerixafor—Mental disorder—Prednisone—asthma	0.000229	0.000478	CcSEcCtD
Plerixafor—Skin disorder—Methylprednisolone—asthma	0.000227	0.000475	CcSEcCtD
Plerixafor—Erythema—Prednisone—asthma	0.000227	0.000475	CcSEcCtD
Plerixafor—Musculoskeletal discomfort—Hydrocortisone—asthma	0.000227	0.000475	CcSEcCtD
Plerixafor—Hyperhidrosis—Triamcinolone—asthma	0.000227	0.000474	CcSEcCtD
Plerixafor—Hyperhidrosis—Methylprednisolone—asthma	0.000226	0.000473	CcSEcCtD
Plerixafor—Insomnia—Hydrocortisone—asthma	0.000225	0.000471	CcSEcCtD
Plerixafor—Paraesthesia—Hydrocortisone—asthma	0.000224	0.000468	CcSEcCtD
Plerixafor—CXCR4—Signaling by GPCR—EDN1—asthma	0.00022	0.00055	CbGpPWpGaD
Plerixafor—Discomfort—Betamethasone—asthma	0.000219	0.000459	CcSEcCtD
Plerixafor—Discomfort—Dexamethasone—asthma	0.000219	0.000459	CcSEcCtD
Plerixafor—Dyspepsia—Hydrocortisone—asthma	0.000219	0.000459	CcSEcCtD
Plerixafor—Pain—Prednisolone—asthma	0.000218	0.000456	CcSEcCtD
Plerixafor—CXCR4—Signaling by GPCR—CCL5—asthma	0.000218	0.000546	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—PLA2G4A—asthma	0.000217	0.000543	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—CCR5—asthma	0.000216	0.000541	CbGpPWpGaD
Plerixafor—Gastrointestinal disorder—Hydrocortisone—asthma	0.000215	0.00045	CcSEcCtD
Plerixafor—CXCR4—Signaling by GPCR—CSF2—asthma	0.000215	0.000537	CbGpPWpGaD
Plerixafor—Fatigue—Hydrocortisone—asthma	0.000215	0.000449	CcSEcCtD
Plerixafor—Musculoskeletal discomfort—Triamcinolone—asthma	0.000214	0.000447	CcSEcCtD
Plerixafor—CXCR4—GPCR downstream signaling—IL2RA—asthma	0.000213	0.000533	CbGpPWpGaD
Plerixafor—Musculoskeletal discomfort—Methylprednisolone—asthma	0.000213	0.000446	CcSEcCtD
Plerixafor—Pain—Hydrocortisone—asthma	0.000213	0.000445	CcSEcCtD
Plerixafor—Anaphylactic shock—Dexamethasone—asthma	0.000213	0.000445	CcSEcCtD
Plerixafor—Anaphylactic shock—Betamethasone—asthma	0.000213	0.000445	CcSEcCtD
Plerixafor—Insomnia—Triamcinolone—asthma	0.000212	0.000444	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—CCR3—asthma	0.000212	0.00053	CbGpPWpGaD
Plerixafor—Insomnia—Methylprednisolone—asthma	0.000212	0.000443	CcSEcCtD
Plerixafor—CXCR4—GPCR downstream signaling—C3—asthma	0.000211	0.000529	CbGpPWpGaD
Plerixafor—Ill-defined disorder—Prednisone—asthma	0.000211	0.000441	CcSEcCtD
Plerixafor—Paraesthesia—Triamcinolone—asthma	0.000211	0.00044	CcSEcCtD
Plerixafor—Feeling abnormal—Prednisolone—asthma	0.00021	0.00044	CcSEcCtD
Plerixafor—Paraesthesia—Methylprednisolone—asthma	0.00021	0.000439	CcSEcCtD
Plerixafor—Shock—Betamethasone—asthma	0.000209	0.000438	CcSEcCtD
Plerixafor—Shock—Dexamethasone—asthma	0.000209	0.000438	CcSEcCtD
Plerixafor—Dyspnoea—Triamcinolone—asthma	0.000209	0.000437	CcSEcCtD
Plerixafor—Nervous system disorder—Dexamethasone—asthma	0.000209	0.000436	CcSEcCtD
Plerixafor—Nervous system disorder—Betamethasone—asthma	0.000209	0.000436	CcSEcCtD
Plerixafor—Dyspepsia—Triamcinolone—asthma	0.000206	0.000432	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—NPY—asthma	0.000206	0.000516	CbGpPWpGaD
Plerixafor—Dyspepsia—Methylprednisolone—asthma	0.000206	0.000431	CcSEcCtD
Plerixafor—Hyperhidrosis—Betamethasone—asthma	0.000206	0.00043	CcSEcCtD
Plerixafor—Hyperhidrosis—Dexamethasone—asthma	0.000206	0.00043	CcSEcCtD
Plerixafor—Feeling abnormal—Hydrocortisone—asthma	0.000205	0.000429	CcSEcCtD
Plerixafor—Malaise—Prednisone—asthma	0.000205	0.000428	CcSEcCtD
Plerixafor—Gastrointestinal pain—Hydrocortisone—asthma	0.000204	0.000426	CcSEcCtD
Plerixafor—Syncope—Prednisone—asthma	0.000204	0.000426	CcSEcCtD
Plerixafor—Urticaria—Prednisolone—asthma	0.000203	0.000424	CcSEcCtD
Plerixafor—Fatigue—Triamcinolone—asthma	0.000202	0.000423	CcSEcCtD
Plerixafor—Fatigue—Methylprednisolone—asthma	0.000202	0.000422	CcSEcCtD
Plerixafor—Pain—Triamcinolone—asthma	0.000201	0.000419	CcSEcCtD
Plerixafor—CXCR4—Signaling by GPCR—PPP2CA—asthma	0.0002	0.000501	CbGpPWpGaD
Plerixafor—Loss of consciousness—Prednisone—asthma	0.0002	0.000417	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—AGTR2—asthma	0.000199	0.000498	CbGpPWpGaD
Plerixafor—Urticaria—Hydrocortisone—asthma	0.000198	0.000414	CcSEcCtD
Plerixafor—Abdominal pain—Hydrocortisone—asthma	0.000197	0.000412	CcSEcCtD
Plerixafor—CXCR4—Signaling by GPCR—CCR5—asthma	0.000196	0.000491	CbGpPWpGaD
Plerixafor—CXCR4—Disease—ITPR1—asthma	0.000196	0.000491	CbGpPWpGaD
Plerixafor—Musculoskeletal discomfort—Dexamethasone—asthma	0.000194	0.000405	CcSEcCtD
Plerixafor—Musculoskeletal discomfort—Betamethasone—asthma	0.000194	0.000405	CcSEcCtD
Plerixafor—CXCR4—Signaling by GPCR—IL2RA—asthma	0.000194	0.000484	CbGpPWpGaD
Plerixafor—Arthralgia—Prednisone—asthma	0.000193	0.000404	CcSEcCtD
Plerixafor—Feeling abnormal—Triamcinolone—asthma	0.000193	0.000404	CcSEcCtD
Plerixafor—Feeling abnormal—Methylprednisolone—asthma	0.000193	0.000403	CcSEcCtD
Plerixafor—Insomnia—Dexamethasone—asthma	0.000192	0.000403	CcSEcCtD
Plerixafor—Insomnia—Betamethasone—asthma	0.000192	0.000403	CcSEcCtD
Plerixafor—Unspecified disorder of skin and subcutaneous tissue—Prednisone—asthma	0.000192	0.000402	CcSEcCtD
Plerixafor—CXCR4—Signaling by GPCR—C3—asthma	0.000192	0.00048	CbGpPWpGaD
Plerixafor—Gastrointestinal pain—Methylprednisolone—asthma	0.000191	0.0004	CcSEcCtD
Plerixafor—Paraesthesia—Dexamethasone—asthma	0.000191	0.0004	CcSEcCtD
Plerixafor—Paraesthesia—Betamethasone—asthma	0.000191	0.0004	CcSEcCtD
Plerixafor—Discomfort—Prednisone—asthma	0.000191	0.000399	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—EDNRB—asthma	0.000191	0.000477	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—TAC1—asthma	0.000189	0.000472	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—NPS—asthma	0.000189	0.000472	CbGpPWpGaD
Plerixafor—Hypersensitivity—Prednisolone—asthma	0.000188	0.000393	CcSEcCtD
Plerixafor—Dyspepsia—Dexamethasone—asthma	0.000187	0.000392	CcSEcCtD
Plerixafor—Dyspepsia—Betamethasone—asthma	0.000187	0.000392	CcSEcCtD
Plerixafor—CXCR4—Disease—CD86—asthma	0.000187	0.000467	CbGpPWpGaD
Plerixafor—Urticaria—Triamcinolone—asthma	0.000186	0.00039	CcSEcCtD
Plerixafor—Urticaria—Methylprednisolone—asthma	0.000186	0.000389	CcSEcCtD
Plerixafor—Anaphylactic shock—Prednisone—asthma	0.000185	0.000388	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—CXCR3—asthma	0.000185	0.000463	CbGpPWpGaD
Plerixafor—Abdominal pain—Methylprednisolone—asthma	0.000185	0.000387	CcSEcCtD
Plerixafor—Gastrointestinal disorder—Betamethasone—asthma	0.000184	0.000384	CcSEcCtD
Plerixafor—Gastrointestinal disorder—Dexamethasone—asthma	0.000184	0.000384	CcSEcCtD
Plerixafor—Hypersensitivity—Hydrocortisone—asthma	0.000184	0.000384	CcSEcCtD
Plerixafor—Fatigue—Betamethasone—asthma	0.000183	0.000384	CcSEcCtD
Plerixafor—Fatigue—Dexamethasone—asthma	0.000183	0.000384	CcSEcCtD
Plerixafor—Shock—Prednisone—asthma	0.000182	0.000381	CcSEcCtD
Plerixafor—Pain—Betamethasone—asthma	0.000182	0.000381	CcSEcCtD
Plerixafor—Pain—Dexamethasone—asthma	0.000182	0.000381	CcSEcCtD
Plerixafor—Nervous system disorder—Prednisone—asthma	0.000182	0.00038	CcSEcCtD
Plerixafor—Skin disorder—Prednisone—asthma	0.00018	0.000376	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—CYBA—asthma	0.000179	0.000449	CbGpPWpGaD
Plerixafor—Hyperhidrosis—Prednisone—asthma	0.000179	0.000375	CcSEcCtD
Plerixafor—Asthenia—Hydrocortisone—asthma	0.000179	0.000374	CcSEcCtD
Plerixafor—CXCR4—Disease—SMAD3—asthma	0.000176	0.000441	CbGpPWpGaD
Plerixafor—Pruritus—Hydrocortisone—asthma	0.000176	0.000369	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—IL5—asthma	0.000176	0.000439	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—PARP1—asthma	0.000176	0.000439	CbGpPWpGaD
Plerixafor—Feeling abnormal—Betamethasone—asthma	0.000175	0.000367	CcSEcCtD
Plerixafor—Feeling abnormal—Dexamethasone—asthma	0.000175	0.000367	CcSEcCtD
Plerixafor—Gastrointestinal pain—Betamethasone—asthma	0.000174	0.000364	CcSEcCtD
Plerixafor—Gastrointestinal pain—Dexamethasone—asthma	0.000174	0.000364	CcSEcCtD
Plerixafor—Hypersensitivity—Triamcinolone—asthma	0.000173	0.000361	CcSEcCtD
Plerixafor—Hypersensitivity—Methylprednisolone—asthma	0.000172	0.000361	CcSEcCtD
Plerixafor—Diarrhoea—Hydrocortisone—asthma	0.00017	0.000356	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—BDKRB2—asthma	0.000169	0.000424	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—POMC—asthma	0.000169	0.000423	CbGpPWpGaD
Plerixafor—Urticaria—Dexamethasone—asthma	0.000169	0.000354	CcSEcCtD
Plerixafor—Urticaria—Betamethasone—asthma	0.000169	0.000354	CcSEcCtD
Plerixafor—Musculoskeletal discomfort—Prednisone—asthma	0.000169	0.000353	CcSEcCtD
Plerixafor—CXCR4—Disease—PPP2CA—asthma	0.000169	0.000422	CbGpPWpGaD
Plerixafor—Dizziness—Prednisolone—asthma	0.000169	0.000353	CcSEcCtD
Plerixafor—Asthenia—Triamcinolone—asthma	0.000168	0.000352	CcSEcCtD
Plerixafor—Abdominal pain—Dexamethasone—asthma	0.000168	0.000352	CcSEcCtD
Plerixafor—Abdominal pain—Betamethasone—asthma	0.000168	0.000352	CcSEcCtD
Plerixafor—Asthenia—Methylprednisolone—asthma	0.000168	0.000351	CcSEcCtD
Plerixafor—Insomnia—Prednisone—asthma	0.000168	0.000351	CcSEcCtD
Plerixafor—Paraesthesia—Prednisone—asthma	0.000166	0.000348	CcSEcCtD
Plerixafor—Pruritus—Triamcinolone—asthma	0.000166	0.000347	CcSEcCtD
Plerixafor—CXCR4—Disease—CCR5—asthma	0.000166	0.000415	CbGpPWpGaD
Plerixafor—Pruritus—Methylprednisolone—asthma	0.000166	0.000346	CcSEcCtD
Plerixafor—Dizziness—Hydrocortisone—asthma	0.000165	0.000344	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—ADCY2—asthma	0.000164	0.00041	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—IL3—asthma	0.000163	0.000408	CbGpPWpGaD
Plerixafor—Dyspepsia—Prednisone—asthma	0.000163	0.000341	CcSEcCtD
Plerixafor—Rash—Prednisolone—asthma	0.000161	0.000336	CcSEcCtD
Plerixafor—Dermatitis—Prednisolone—asthma	0.000161	0.000336	CcSEcCtD
Plerixafor—Diarrhoea—Methylprednisolone—asthma	0.00016	0.000335	CcSEcCtD
Plerixafor—Fatigue—Prednisone—asthma	0.00016	0.000334	CcSEcCtD
Plerixafor—Headache—Prednisolone—asthma	0.00016	0.000334	CcSEcCtD
Plerixafor—Constipation—Prednisone—asthma	0.000158	0.000331	CcSEcCtD
Plerixafor—Vomiting—Hydrocortisone—asthma	0.000158	0.000331	CcSEcCtD
Plerixafor—CXCR4—Disease—PDGFB—asthma	0.000158	0.000394	CbGpPWpGaD
Plerixafor—Rash—Hydrocortisone—asthma	0.000157	0.000328	CcSEcCtD
Plerixafor—Dermatitis—Hydrocortisone—asthma	0.000157	0.000328	CcSEcCtD
Plerixafor—Headache—Hydrocortisone—asthma	0.000156	0.000326	CcSEcCtD
Plerixafor—Dizziness—Triamcinolone—asthma	0.000155	0.000324	CcSEcCtD
Plerixafor—Dizziness—Methylprednisolone—asthma	0.000155	0.000324	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—KNG1—asthma	0.000154	0.000385	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—POMC—asthma	0.000154	0.000384	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—AGTR1—asthma	0.000153	0.000383	CbGpPWpGaD
Plerixafor—Feeling abnormal—Prednisone—asthma	0.000153	0.000319	CcSEcCtD
Plerixafor—Asthenia—Betamethasone—asthma	0.000153	0.000319	CcSEcCtD
Plerixafor—Asthenia—Dexamethasone—asthma	0.000153	0.000319	CcSEcCtD
Plerixafor—Gastrointestinal pain—Prednisone—asthma	0.000152	0.000317	CcSEcCtD
Plerixafor—Nausea—Prednisolone—asthma	0.000151	0.000317	CcSEcCtD
Plerixafor—Pruritus—Betamethasone—asthma	0.000151	0.000315	CcSEcCtD
Plerixafor—Pruritus—Dexamethasone—asthma	0.000151	0.000315	CcSEcCtD
Plerixafor—CXCR4—Signaling by GPCR—CCL2—asthma	0.00015	0.000376	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—IL6R—asthma	0.00015	0.000375	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CXCL10—asthma	0.00015	0.000374	CbGpPWpGaD
Plerixafor—Vomiting—Triamcinolone—asthma	0.000149	0.000312	CcSEcCtD
Plerixafor—CXCR4—GPCR downstream signaling—RHOA—asthma	0.000149	0.000373	CbGpPWpGaD
Plerixafor—Vomiting—Methylprednisolone—asthma	0.000149	0.000311	CcSEcCtD
Plerixafor—Nausea—Hydrocortisone—asthma	0.000148	0.000309	CcSEcCtD
Plerixafor—Rash—Triamcinolone—asthma	0.000148	0.000309	CcSEcCtD
Plerixafor—Dermatitis—Triamcinolone—asthma	0.000148	0.000309	CcSEcCtD
Plerixafor—Rash—Methylprednisolone—asthma	0.000148	0.000309	CcSEcCtD
Plerixafor—Dermatitis—Methylprednisolone—asthma	0.000147	0.000308	CcSEcCtD
Plerixafor—Urticaria—Prednisone—asthma	0.000147	0.000308	CcSEcCtD
Plerixafor—Headache—Triamcinolone—asthma	0.000147	0.000307	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—NTRK1—asthma	0.000147	0.000367	CbGpPWpGaD
Plerixafor—Headache—Methylprednisolone—asthma	0.000147	0.000307	CcSEcCtD
Plerixafor—Abdominal pain—Prednisone—asthma	0.000147	0.000306	CcSEcCtD
Plerixafor—Diarrhoea—Dexamethasone—asthma	0.000146	0.000305	CcSEcCtD
Plerixafor—Diarrhoea—Betamethasone—asthma	0.000146	0.000305	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—ADRB2—asthma	0.000145	0.000363	CbGpPWpGaD
Plerixafor—Dizziness—Betamethasone—asthma	0.000141	0.000294	CcSEcCtD
Plerixafor—Dizziness—Dexamethasone—asthma	0.000141	0.000294	CcSEcCtD
Plerixafor—CXCR4—Disease—NOS2—asthma	0.000141	0.000352	CbGpPWpGaD
Plerixafor—Nausea—Triamcinolone—asthma	0.000139	0.000291	CcSEcCtD
Plerixafor—Nausea—Methylprednisolone—asthma	0.000139	0.000291	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—ITPR1—asthma	0.000137	0.000344	CbGpPWpGaD
Plerixafor—Hypersensitivity—Prednisone—asthma	0.000137	0.000286	CcSEcCtD
Plerixafor—Vomiting—Betamethasone—asthma	0.000135	0.000283	CcSEcCtD
Plerixafor—Vomiting—Dexamethasone—asthma	0.000135	0.000283	CcSEcCtD
Plerixafor—CXCR4—Signaling by GPCR—RHOA—asthma	0.000135	0.000338	CbGpPWpGaD
Plerixafor—Rash—Dexamethasone—asthma	0.000134	0.000281	CcSEcCtD
Plerixafor—Rash—Betamethasone—asthma	0.000134	0.000281	CcSEcCtD
Plerixafor—Dermatitis—Dexamethasone—asthma	0.000134	0.00028	CcSEcCtD
Plerixafor—Dermatitis—Betamethasone—asthma	0.000134	0.00028	CcSEcCtD
Plerixafor—Headache—Betamethasone—asthma	0.000133	0.000279	CcSEcCtD
Plerixafor—Headache—Dexamethasone—asthma	0.000133	0.000279	CcSEcCtD
Plerixafor—Asthenia—Prednisone—asthma	0.000133	0.000278	CcSEcCtD
Plerixafor—Pruritus—Prednisone—asthma	0.000131	0.000274	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—CD86—asthma	0.000131	0.000327	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—CXCL8—asthma	0.000131	0.000327	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—EDN1—asthma	0.00013	0.000325	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CCL5—asthma	0.000129	0.000322	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—PLA2G4A—asthma	0.000128	0.000321	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CSF2—asthma	0.000127	0.000317	CbGpPWpGaD
Plerixafor—Diarrhoea—Prednisone—asthma	0.000127	0.000265	CcSEcCtD
Plerixafor—Nausea—Betamethasone—asthma	0.000126	0.000264	CcSEcCtD
Plerixafor—Nausea—Dexamethasone—asthma	0.000126	0.000264	CcSEcCtD
Plerixafor—CXCR4—Disease—IL6R—asthma	0.000126	0.000316	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—IL2—asthma	0.000125	0.000313	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—SMAD3—asthma	0.000124	0.000309	CbGpPWpGaD
Plerixafor—Dizziness—Prednisone—asthma	0.000123	0.000256	CcSEcCtD
Plerixafor—CXCR4—Signaling by GPCR—CXCL8—asthma	0.000119	0.000297	CbGpPWpGaD
Plerixafor—CXCR4—Disease—SERPINE1—asthma	0.000118	0.000296	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—PPP2CA—asthma	0.000118	0.000296	CbGpPWpGaD
Plerixafor—Vomiting—Prednisone—asthma	0.000118	0.000246	CcSEcCtD
Plerixafor—Rash—Prednisone—asthma	0.000117	0.000244	CcSEcCtD
Plerixafor—Dermatitis—Prednisone—asthma	0.000117	0.000244	CcSEcCtD
Plerixafor—Headache—Prednisone—asthma	0.000116	0.000243	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—CCR5—asthma	0.000116	0.00029	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—IL2RA—asthma	0.000114	0.000286	CbGpPWpGaD
Plerixafor—CXCR4—Disease—RHOA—asthma	0.000114	0.000286	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—IL2—asthma	0.000114	0.000284	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—C3—asthma	0.000113	0.000284	CbGpPWpGaD
Plerixafor—CXCR4—Disease—NOS3—asthma	0.000113	0.000283	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—PDGFB—asthma	0.00011	0.000276	CbGpPWpGaD
Plerixafor—Nausea—Prednisone—asthma	0.00011	0.00023	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—LEP—asthma	0.000106	0.000264	CbGpPWpGaD
Plerixafor—CXCR4—Disease—CD4—asthma	0.000104	0.00026	CbGpPWpGaD
Plerixafor—CXCR4—Disease—PTGS2—asthma	0.000103	0.000258	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—FN1—asthma	9.96e-05	0.000249	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—POMC—asthma	9.07e-05	0.000227	CbGpPWpGaD
Plerixafor—CXCR4—Disease—PTEN—asthma	9.01e-05	0.000225	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CCL2—asthma	8.87e-05	0.000222	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—IL6R—asthma	8.85e-05	0.000221	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—EGFR—asthma	8.68e-05	0.000217	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—SERPINE1—asthma	8.29e-05	0.000207	CbGpPWpGaD
Plerixafor—CXCR4—Disease—STAT3—asthma	8.06e-05	0.000202	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—RHOA—asthma	7.99e-05	0.0002	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—NOS3—asthma	7.91e-05	0.000198	CbGpPWpGaD
Plerixafor—CXCR4—Disease—TGFB1—asthma	7.47e-05	0.000187	CbGpPWpGaD
Plerixafor—CXCR4—Disease—EGFR—asthma	7.32e-05	0.000183	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CXCL8—asthma	7.02e-05	0.000176	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—IL2—asthma	6.71e-05	0.000168	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—IL6—asthma	6.67e-05	0.000167	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—MMP9—asthma	6.35e-05	0.000159	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—PTEN—asthma	6.31e-05	0.000158	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—VEGFA—asthma	5.7e-05	0.000143	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—STAT3—asthma	5.64e-05	0.000141	CbGpPWpGaD
Plerixafor—CXCR4—Disease—IL6—asthma	5.63e-05	0.000141	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—TGFB1—asthma	5.23e-05	0.000131	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—EGFR—asthma	5.13e-05	0.000128	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—IL6—asthma	3.94e-05	9.86e-05	CbGpPWpGaD
